We can assess the patient’s tumor burden and disease progression based on biochemical indicators (e.g., hemoglobin, serum calcium, β2-microglobulin(β2M), serum albumin, lactate dehydrogenase(LDH)) to determine the stage of the disease (4). The gene discussed is ALB; the disease is neoplasm.